Co-proxamol
From Wikipedia, the free encyclopedia
|
Co-proxamol
|
|
| Combination of | |
| Dextropropoxyphene | Opioid analgesic |
| Paracetamol | Non-opioid analgesic |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Co-proxamol (BAN), (also coproxamol) is a compound analgesic, a combination of the analgesics dextropropoxyphene (an opioid) and paracetamol.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) decided in 2005 to withdraw Co-proxamol from the market following advice from the Committee on Safety of Medicines (CSM) that Co-proxamol is little more effective than paracetamol alone as an analgesic, but that it was associated with higher fatality rates if a drug overdose were intentionally or inadvertently taken. The decision provoked some outcry from long-term users of the drug.
[edit] References
- Suicide painkiller withdrawn. The Times (January 31, 2005).
- Painkiller scrapped over suicides. BBC News (January 31, 2005).
- Co-proxamol to be withdrawn from the market. Medicines and Healthcare products Regulatory Agency (31 January 2005).
- Withdrawal of co-proxamol. Medicines and Healthcare products Regulatory Agency (17 January 2007).
[edit] See also
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||||||||||||||||||||||
